StockData
UroGen Pharma Ltd. logo

UroGen Pharma Ltd. (URGN) stock

URGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$29.79−0.08 (-0.27%)

Close on Nov 18, 2026Market cap $1.46BP/E –Yield –

UroGen Pharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

UroGen Pharma's EV/EBITDA was 92.1× on Jan 31, 2018.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2018Jan 31, 201892.1×+27.5
2017Dec 29, 201764.6×–

More UroGen Pharma figures

See a number that looks wrong?